Accelerated Resolution Therapy (ART) for Psychological Trauma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01559688
Recruitment Status : Completed
First Posted : March 21, 2012
Last Update Posted : October 30, 2013
United States Department of Defense
Information provided by (Responsible Party):
University of South Florida

Brief Summary:

Service members and veterans often experience symptoms of psychological trauma following combat deployments. While efforts are being made in the military and at the Veteran's Affairs to meet the large number of soldiers and veterans experiencing symptoms of psychological trauma, there remains a need to evaluate new treatments, particularly those that are designed to be brief in length.

A new therapy, known as Accelerated Resolution Therapy (ART), is a type of psychological therapy that is designed for rapid resolution of symptoms of psychological trauma. This approach uses a combination of talking and sets of eye movements guided by the therapist. During therapy, this interactive personal guidance is thought to be helpful in resolving problems (such as bad memories).

The purpose of this study is to:

  1. Evaluate how effective ART is in treating symptoms of psychological trauma among non-active duty veterans who served in Operation Iraqi Freedom and Operation Enduring Freedom in Iraq and in Afghanistan or other combat conflicts.
  2. Learn if there is improvement in symptoms of psychological trauma (such as bad memories, anxiety, depression, and guilt) after receiving Accelerated Resolution Therapy (ART).

Condition or disease Intervention/treatment Phase
Psychological Trauma PTSD Behavioral: Accelerated Resolution Therapy (ART) Behavioral: Waitlist Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 80 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Study Start Date : July 2011
Actual Primary Completion Date : October 2013
Actual Study Completion Date : October 2013

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Experimental: ART therapy group
Participants in this arm will receive 2-5 sessions of ART therapy, depending on individual progress. Each session will last 60-90 minutes over a 2-week period.
Behavioral: Accelerated Resolution Therapy (ART)
ART is a cognitive based therapy which integrates an eye movement technique while focusing on a problem (traumatic experience) during the therapy session.
Active Comparator: Waitlist
Participants in this group will receive 2 fitness assessment or career counseling sessions. Each session will last 60-90 minutes over a 2-week period. Upon completion of this arm, participants will be offered the choice to start ART therapy.
Behavioral: Waitlist
Fitness assessment or career counseling

Primary Outcome Measures :
  1. Change in PTSD Checklist (PCL-M) score from baseline to end of treatment [ Time Frame: approximately 2 weeks ]
    This questionnaire asks about symptoms in response to "stressful military experiences."

Secondary Outcome Measures :
  1. Change in psychological wellness as measured by Brief Symptom Inventory from baseline to endpoint [ Time Frame: approximately 2 weeks ]
  2. Change in trauma-related guilt as measured by Trauma-Related Guilt Inventory from baseline to endpoint [ Time Frame: approximately 2 weeks ]
  3. Change in depressive symptoms as measured by the Center for Epidemiologic Depression (CES-D) scale from baseline to endpoint [ Time Frame: approximately 2 weeks ]
  4. Change in anxiety symptoms as measured by State-Trait Inventory from baseline to endpoint [ Time Frame: approximately 2 weeks ]
  5. Change in anger as measured by Aggression Questionnaire from baseline to endpoint [ Time Frame: approximately 2 weeks ]
  6. Change in sleep quality as measured by the Pittsburgh Sleep Quality Index (PSQI) from baseline to endpoint [ Time Frame: approximately 2 weeks ]
  7. Change in self-compassion scale score from baseline to endpoint [ Time Frame: approximately 2 weeks ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Non-active duty U.S. veteran of any prior deployment(s) with recruitment emphasis on those who previously served in Iraq and/or Afghanistan (OIF and OEF).
  • At least 18 years of age.
  • Symptoms indicative of psychological trauma. This includes a score of >40 on the PCL-M Checklist, or in the absence of a score >40, therapist assessment of symptoms of PTSD, as determined from the Checklist for Accelerated Resolution Therapy (ART) Standard Protocol. Individuals with previous treatment for psychological trauma, yet with residual symptoms, will be eligible.
  • Ability to read and speak English to complete survey questions.
  • Denial of suicidal ideation or intent, including homicidal ideation or intent, and no evidence of psychotic behavior or being in psychological crisis

Exclusion Criteria:

  • Brain injury prohibiting speech, writing, and purposeful actions
  • Identified to have current suicidal ideation
  • Major psychiatric disorder concomitant to symptoms of psychological trauma
  • Currently undergoing substance abuse treatment
  • Previous diagnosis of eye movement disorder
  • Any medical condition that, in the judgment of the Principal Investigator and/or ART therapist, may place the individual at high risk due to a potential heightened emotional reaction

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01559688

United States, Florida
University of South Florida
Tampa, Florida, United States, 33612
Sponsors and Collaborators
University of South Florida
United States Department of Defense
Principal Investigator: Kevin Kip, PhD University of South Florida